Amedisys, Inc. (AMED) Stock Overview
Explore Amedisys, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Amedisys, Inc. (AMED)
Key Financials
Key Financials
Market Cap
3.3B
P/E Ratio
30.65
EPS (TTM)
$2.57
ROE
0.09%
AMED Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Amedisys, Inc. (AMED) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.65 and a market capitalization of 3.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.